Sofinnova Partners

Sofinnova Partners is a leading European venture capital firm, established in 1972, that focuses on life sciences, healthcare, and sustainability. With offices in Paris, London, and Milan, the firm manages over €2.8 billion in assets and has backed more than 500 companies globally. Sofinnova Partners specializes in supporting companies across the full spectrum of life sciences, from seed-stage to later growth, with dedicated funds for biopharmaceuticals, medical devices, digital medicine, and industrial biotechnology. The firm is known for its hands-on approach, partnering with entrepreneurs to develop transformative technologies that address significant healthcare challenges. Notable investments include groundbreaking companies in gene therapy, precision medicine, and sustainability-focused biotech. Sofinnova’s portfolio includes innovations across sectors such as biopharma, medtech, and AI-powered digital health solutions. Sofinnova has a strong track record of creating market leaders, driven by its deep scientific expertise and commitment to long-term partnerships. Through strategies like Sofinnova Capital and Sofinnova Crossover, the firm supports companies from inception through IPOs or acquisition, playing a critical role in advancing innovations that improve lives globally.